Anxiety
WHAT IS ANXIETY? WHEN DOES IT BECOME A DISORDER?
Fear/anxiety itself is not inherently bad.
Normal anxiety is adaptive:
o Protective, survival-relevant.
o Promotes vigilance, avoidance learning, and prepares the
body for action.
Anxiety disorder = maladaptive:
o A harmful dysfunction/disorder of the normal anxiety process.
Persistence (outlasts threat/context)
Generalisation (spreads to safe contexts)
Functional impairment/distress (work, relationships,
sleep)
Not proportional to actual risk
Key challenge: anxiety is on a spectrum.
o Extremes (clearly normal vs clearly disordered) are easy.
o The difficult part is defining the “crossing point” where impact
becomes clinically meaningful.
What changes to cause this pathology?
WHY DEFINITIONS MATTER (DSM-5) — AND WHY THEY’RE A
PROBLEM
To study anxiety disorders, need a standardised clinical
definition:
o Helps diagnosis in humans.
o Helps define what researchers are trying to model/measure.
DSM (Diagnostic and Statistical Manual) is the standard:
o DSM-1 → DSM-5 (with minor updates).
o Compare individuals to criteria and determine diagnosis.
But anxiety disorders are subtypes (e.g., GAD, panic disorder etc.).
DSM categories are not fixed over time:
o Example: PTSD used to be classed under anxiety disorders but
was reclassified into its own category.
o Therefore: what you’re attempting to model in the lab can
shift, and makes it difficult to interpret past work with old
definitions/diagnoses.
DSM definitions are agreed “by committee,” and there is
disagreement:
o Some think rigid definitions help - admin, diagnosis.
o Others think they’re too rigid (near-threshold people may
miss diagnosis) - unhelpful for treatments for individual
patients with variable pathology.
o Sociocultural factors can affect relevance across populations.
Symptoms overlap across diagnoses:
o Signs/symptoms are often not unique to one disorder.
, o Boundaries between diagnoses are blurred.
o Therefore: patient group for one disorder is heterogenous ->
weak translational/model validity.
THE “ENDOPHENOTYPE” IDEA (WHY IT MATTERS FOR RESEARCH)
If human condition cannot be uniquely defined, becomes extremely
hard to:
o Study “basic biology” vs “condition biology.”
o Judge whether an intervention worked.
One workaround: focus on endophenotypes:
o A measurable subset of signs/symptoms with clearer
biological linkage.
o More tractable than “the whole disorder.”
Alternative framework:
o A biologically linked “index” approach (described as
controversial).
o Used to think differently about psychiatric risk/likelihood (e.g.,
via family risk).
ORIGINS OF ANXIETY: CENTRAL VS PERIPHERAL (INTEROCEPTION
+ LEARNING)
Key point: anxiety is a “central problem” (brain), but peripheral physiology
can strongly shape it.
Humans learn associations between peripheral physiological
changes and subjective anxiety.
Example drug: isoprenaline
o Acts peripherally (β-adrenoceptors), does not cross BBB.
o Increases heart rate (peripheral effect).
o If given without explanation, people may report feeling
anxious.
Interpretation:
o The brain receives physiological information and interprets it
(“interoception”).
o If a person has learned “heart racing = danger,” then
peripheral changes can trigger the psychological experience
of anxiety.
Research implication:
o In humans, previous experiences (longitudinal learning
history) shape anxiety expression.
o A standard lab rat “straight out of the cage” may not have
comparable learned associations.
o So what exactly are we testing in animal work?
WHAT IS ANXIETY? WHEN DOES IT BECOME A DISORDER?
Fear/anxiety itself is not inherently bad.
Normal anxiety is adaptive:
o Protective, survival-relevant.
o Promotes vigilance, avoidance learning, and prepares the
body for action.
Anxiety disorder = maladaptive:
o A harmful dysfunction/disorder of the normal anxiety process.
Persistence (outlasts threat/context)
Generalisation (spreads to safe contexts)
Functional impairment/distress (work, relationships,
sleep)
Not proportional to actual risk
Key challenge: anxiety is on a spectrum.
o Extremes (clearly normal vs clearly disordered) are easy.
o The difficult part is defining the “crossing point” where impact
becomes clinically meaningful.
What changes to cause this pathology?
WHY DEFINITIONS MATTER (DSM-5) — AND WHY THEY’RE A
PROBLEM
To study anxiety disorders, need a standardised clinical
definition:
o Helps diagnosis in humans.
o Helps define what researchers are trying to model/measure.
DSM (Diagnostic and Statistical Manual) is the standard:
o DSM-1 → DSM-5 (with minor updates).
o Compare individuals to criteria and determine diagnosis.
But anxiety disorders are subtypes (e.g., GAD, panic disorder etc.).
DSM categories are not fixed over time:
o Example: PTSD used to be classed under anxiety disorders but
was reclassified into its own category.
o Therefore: what you’re attempting to model in the lab can
shift, and makes it difficult to interpret past work with old
definitions/diagnoses.
DSM definitions are agreed “by committee,” and there is
disagreement:
o Some think rigid definitions help - admin, diagnosis.
o Others think they’re too rigid (near-threshold people may
miss diagnosis) - unhelpful for treatments for individual
patients with variable pathology.
o Sociocultural factors can affect relevance across populations.
Symptoms overlap across diagnoses:
o Signs/symptoms are often not unique to one disorder.
, o Boundaries between diagnoses are blurred.
o Therefore: patient group for one disorder is heterogenous ->
weak translational/model validity.
THE “ENDOPHENOTYPE” IDEA (WHY IT MATTERS FOR RESEARCH)
If human condition cannot be uniquely defined, becomes extremely
hard to:
o Study “basic biology” vs “condition biology.”
o Judge whether an intervention worked.
One workaround: focus on endophenotypes:
o A measurable subset of signs/symptoms with clearer
biological linkage.
o More tractable than “the whole disorder.”
Alternative framework:
o A biologically linked “index” approach (described as
controversial).
o Used to think differently about psychiatric risk/likelihood (e.g.,
via family risk).
ORIGINS OF ANXIETY: CENTRAL VS PERIPHERAL (INTEROCEPTION
+ LEARNING)
Key point: anxiety is a “central problem” (brain), but peripheral physiology
can strongly shape it.
Humans learn associations between peripheral physiological
changes and subjective anxiety.
Example drug: isoprenaline
o Acts peripherally (β-adrenoceptors), does not cross BBB.
o Increases heart rate (peripheral effect).
o If given without explanation, people may report feeling
anxious.
Interpretation:
o The brain receives physiological information and interprets it
(“interoception”).
o If a person has learned “heart racing = danger,” then
peripheral changes can trigger the psychological experience
of anxiety.
Research implication:
o In humans, previous experiences (longitudinal learning
history) shape anxiety expression.
o A standard lab rat “straight out of the cage” may not have
comparable learned associations.
o So what exactly are we testing in animal work?
